Characterization of the Functional and Structural Development of the Human Neonatal Brain From 30 Wks to 45 Wks ga
The Major Goal of This Project is to Characterize the Structural and Functional Development of Cortical Plate and White Matter of the Human Neonatal Brain From the Equivalent 30 Gestational Weeks to 45 Gestational Weeks.
2 other identifiers
observational
102
1 country
1
Brief Summary
The major goal of this project is to characterize the structural and functional development of cortical plate and white matter of the human neonatal brain from the equivalent 30 gestational weeks to 45 gestational weeks. The project is sponsored by niH R01MH092535. Furthermore, it is related to the blue print project of transcriptome atlas (niH RC2MH089921) with at least 36 million funding also sponsored by niH. Revealing detailed anatomy at different equivalent gestational ages of human neonatal brain not only aids in understanding this highly ordered process, but also provides clues to detect abnormalities caused by genetic or environmental factors. Cerebral vascular measurements offer important information on cerebral metabolism. However, either anatomical or functional studies of human brain development during this period are surprisingly scarce. Diffusion tensor imaging (DTi), a recently developed technology of magnetic resonance imaging (MRi), is capable of noninvasively delineating macroscopic anatomical components with high contrast and revealing structures at the microscopic level. Cerebral vascular quantification including cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRo2) can also be obtained through noninvasive MRi, specifically arterial spin labeling (aSL) and T2-relaxation under spin tagging (TRuST) MRi. in this proposed study, the structure and function of neonatal brain will be explored using noninvasive MRi technologies. 102 infants will be recruited and no sedation will be applied during MRi. The resultant database will provide reference standards for diagnostic radiology of premature newborns and reveal the vascular activities of these newborn brains. Specifically, three aims will be achieved:
- 1.To delineate the anatomical development of complex structure in the cerebral wall and white matter tracts of neonatal brains at different equivalent gestational ages.
- 2.To quantify the cerebral blood flow and metabolic rate of oxygen of neonatal brain.
- 3.To correlate the structural and functional measurements with the gene transcriptome results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 13, 2014
CompletedFirst Posted
Study publicly available on registry
June 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedSeptember 9, 2019
September 1, 2019
6.5 years
June 13, 2014
September 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To observe normal brain development in neonates using MR imaging.
neonates from 30 wg to 45 wg
Study Arms (1)
No treatment
All subjects studied are normal healthy neonates without a condition. MRI will be used to assess normal brain development.
Interventions
non-invasive MRI techniques (DTI) and (ASL) will be used to assess normal brain development. DTI is capable of invasively delineating macroscopic anatomic components with high contrast and revealing structures at the microscopic level. ASL is capable of measuring cerebral blood flow and cerebral metabolic rate of oxygen.
Eligibility Criteria
Neonates in the neonatal intensive care unit at Parkland Hospital
You may qualify if:
- Normal infants of both genders
- Any race or ethnicity
- Inborn preterm delivered from 30-45 weeks gestation
- Medically stable for transport i.e. requiring at most a nasal canula \< 2 liters for respiratory support.
You may not qualify if:
- Infants not delivered from 30-45 weeks gestation
- Infants who may have a neurological event at birth
- Presence of known or suspected congenital anomalies such as chromosomal anomalies
- Major congenital heart disease or congenital infection
- Substance abuse and any grade\>1 of intraventricular hemorrhage (IVH) by cranial ultrasound
- Presence of cystic periventricular leukomalacia (PVL) by cranial ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkland Hospital
Dallas, Texas, 75390, United States
Related Publications (1)
Huang H, Jeon T, Sedmak G, Pletikos M, Vasung L, Xu X, Yarowsky P, Richards LJ, Kostovic I, Sestan N, Mori S. Coupling diffusion imaging with histological and gene expression analysis to examine the dynamics of cortical areas across the fetal period of human brain development. Cereb Cortex. 2013 Nov;23(11):2620-31. doi: 10.1093/cercor/bhs241. Epub 2012 Aug 28.
PMID: 22933464BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Hao Huang, PhD
University of Texas Southwestern Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2014
First Posted
June 23, 2014
Study Start
February 1, 2012
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
September 9, 2019
Record last verified: 2019-09